Concourse Financial Group Securities, Inc. Xencor Inc Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 100.0%
Shares
29 transactions
Others Institutions Holding XNCR
# of Institutions
211Shares Held
80.7MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY11.1MShares$154 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA10.5MShares$146 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.1MShares$98.7 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.14MShares$85.4 Million4.16% of portfolio
-
State Street Corp Boston, MA3.82MShares$53.1 Million0.0% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $830M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...